squamous carcinomas (SCC) for risk stratification is not clear. Many recommend use of both
p16 immunohistochemistry and HPV in situ hybridization (ISH). A significant minority of
tumors are p16 positive and HPV ISH negative, the significance of which is unclear. Methods
Two hundred thirty-nine oropharyngeal SCC were tested by immunohistochemistry for p16
and by ISH for high-risk HPV. For p16 positive, HPV ISH negative cases, PCR was …